SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-022600
Filing Date
2024-03-14
Accepted
2024-03-14 16:00:24
Documents
24
Period of Report
2024-03-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0201786-8k_unicyc.htm   iXBRL 8-K 53520
2 CERTIFICATE OF ELIMINATION OF SERIES A-1 CONVERTIBLE PREFERRED STOCK ea020178601ex3-1_unicyc.htm EX-3.1 11794
3 CERTIFICATE OF ELIMINATION OF SERIES A-2 CONVERTIBLE PREFERRED STOCK ea020178601ex3-2_unicyc.htm EX-3.2 11768
4 CERTIFICATE OF ELIMINATION OF SERIES A-3 CONVERTIBLE PREFERRED STOCK ea020178601ex3-3_unicyc.htm EX-3.3 9185
5 CERTIFICATE OF ELIMINATION OF SERIES A-4 CONVERTIBLE PREFERRED STOCK ea020178601ex3-4_unicyc.htm EX-3.4 9192
6 CERTIFICATE OF ELIMINATION OF SERIES A-5 CONVERTIBLE PREFERRED STOCK ea020178601ex3-5_unicyc.htm EX-3.5 9192
7 AMENDED AND RESTATED CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMIT ea020178601ex3-6_unicyc.htm EX-3.6 87570
8 FORM OF AMENDED AND RESTATED TRANCHE A WARRANT ea020178601ex4-1_unicyc.htm EX-4.1 61892
9 FORM OF AMENDED AND RESTATED TRANCHE B WARRANT ea020178601ex4-2_unicyc.htm EX-4.2 60911
10 FORM OF AMENDED AND RESTATED TRANCHE C WARRANT ea020178601ex4-3_unicyc.htm EX-4.3 61793
11 FORM OF EXCHANGE AGREEMENT, DATED MARCH 13, 2024, BY AND BETWEEN UNICYCIVE THERA ea020178601ex10-1_unicyc.htm EX-10.1 54234
  Complete submission text file 0001213900-24-022600.txt   701746

Data Files

Seq Description Document Type Size
12 XBRL SCHEMA FILE uncy-20240313.xsd EX-101.SCH 3018
13 XBRL LABEL FILE uncy-20240313_lab.xml EX-101.LAB 34240
14 XBRL PRESENTATION FILE uncy-20240313_pre.xml EX-101.PRE 22361
25 EXTRACTED XBRL INSTANCE DOCUMENT ea0201786-8k_unicyc_htm.xml XML 3818
Mailing Address 4300 EL CAMINO REAL, SUITE 210 LOS ALTOS CA 94022
Business Address 4300 EL CAMINO REAL, SUITE 210 LOS ALTOS CA 94022 650-384-0642
Unicycive Therapeutics, Inc. (Filer) CIK: 0001766140 (see all company filings)

IRS No.: 813638692 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40582 | Film No.: 24749607
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)